First Tracks Biotherapeutics, Inc. (TRAX) insider trading
Over the last 12 months, 0 insiders bought $0 and 2 insiders sold $66.7M of First Tracks Biotherapeutics, Inc. stock on the open market, according to SEC Form 4 filings.
Latest insider buys and sells
- Sep 2, 2026: Ware J. Anthony sold 39,265 shares ($1.76M)
- Apr 20, 2026: EcoR1 Capital, LLC sold 4,705,575 shares ($65.0M)